Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFκB

Cell adhesion molecules are critical in monocyte (MN) recruitment in immune-mediated and hematologic diseases. We investigated the novel role of recombinant human migration inhibitory factor (rhMIF) in up-regulating vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (IC...

Full description

Saved in:
Bibliographic Details
Published in:Blood Vol. 107; no. 6; pp. 2252 - 2261
Main Authors: Amin, M. Asif, Haas, Christian S., Zhu, Kui, Mansfield, Pamela J., Kim, Michael J., Lackowski, Nicholas P., Koch, Alisa E.
Format: Journal Article
Language:English
Published: Washington, DC Elsevier Inc 15-03-2006
The Americain Society of Hematology
The American Society of Hematology
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cell adhesion molecules are critical in monocyte (MN) recruitment in immune-mediated and hematologic diseases. We investigated the novel role of recombinant human migration inhibitory factor (rhMIF) in up-regulating vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) and their signaling pathways in human MNs. rhMIF-induced expression of VCAM-1 and ICAM-1 was significantly higher compared with nonstimulated MNs. rhMIF induced MN VCAM-1 and ICAM-1 expression in a concentration-dependent manner (P < .05). Antisense oligodeoxynucleotides (ODNs) and inhibitors of Src, PI3K, p38, and NFκB significantly reduced rhMIF-induced MN VCAM-1 and ICAM-1 expression (P < .05). However, Erk1/2 and Jak2 were not involved. Silencing RNA directed against MIF, and inhibitors of Src, PI3K, NFκB, anti–VCAM-1, and anti–ICAM-1 significantly inhibited rhMIF-induced adhesion of HL-60 cells to human dermal microvascular endothelial cells (HMVECs) or an endothelial cell line, HMEC-1, in cell adhesion assays, suggesting the functional significance of MIF-induced adhesion molecules (P < .05). rhMIF also activated MN phospho-Src, -Akt, and -NFκB in a time-dependent manner. rhMIF induced VCAM-1 and ICAM-1 up-regulation in 12 hours via Src, PI3K, and NFκB as shown by Western blotting and immunofluorescence. MIF and MIF-dependent signaling pathways may be a potential target for treating diseases characterized by up-regulation of cell adhesion molecules.
Bibliography:The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 U.S.C. section 1734.
Supported by funds from the Veterans Administration Research Services (A.E.K.) and the William D. Robinson and Frederick Huetwell Endowment (A.E.K.) for Arthritis Research and the Gallagher Professorship (A.E.K.) for Arthritis Research. Additional support included funds from the National Institute of Health (grants AI40987, HL58695, and AR48267) (A.E.K.), and a postdoctoral fellowship grant from the American Heart Association (AHA).
Prepublished online as Blood First Edition Paper,November 29, 2005; DOI 10.1182/blood-2005-05-2011.
Reprints: Alisa E. Koch, University of Michigan Medical School, 1150 W Medical Center Dr, 5520B, MSRB1, Ann Arbor, MI 48109; e-mail: aekoch@umich.edu.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2005-05-2011